Epstein-Barr virus (EBV) infection and p53 protein expression in gastric carcinoma

Virus Research

Volumn 118, Issue 1-2, 2006, Pages 115-119

  Szkaradkiewicz, Andrzej ^a   Majewski, Wacław ^a   Wal, Marzena ^a   Czyzak, Mirosław ^a   Majewski, Przemysław ^a   Bierła, Joanna ^a   Kuch, Alicja ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Epstein Barr virus; Gastric carcinoma; p53 protein; Tumorigenesis

Indexed keywords

PROTEIN P53;

ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LABORATORY DIAGNOSIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; STOMACH CARCINOGENESIS; VIRUS CARCINOGENESIS; VIRUS INFECTION;

ADENOCARCINOMA; ADULT; AGED; ANTIBODIES, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; RNA, VIRAL; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

HELICOBACTER PYLORI; HUMAN HERPESVIRUS 4;

EID: 33646054536     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2005.12.001     Document Type: Article

References (32)

1. Anagnostopoulos I., and Hummel M. Epstein-Barr virus in tumours. Histopathology 29 (1996) 297-315
2. Czopek J.P., Stojak M., Sińczak A., Popiela T., Kulig J., Rudzki Z., and Stachura J. EBV-positive gastric carcinomas in Poland. Pol. J. Pathol. 2 (2003) 123-128
3. Fuchs C.S., and Mayer R.J. Gastric carcinoma. N. Engl. J. Med. 333 (1995) 32-41
4. Fukayama M., Hayashi Y., Iwasaki Y., Chong J., Ooba T., Takizawa T., Koike M., Miyaki M., Mizutani S., and Hirai K. Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab. Invest. 71 (1994) 73-81
5. Genta R.M., Robertson G.O., and Graham D.Y. Simultaneous visualization of Helicobacter pylori: a new stain. Hum. Pathol. 25 (1994) 221-226
6. Gulley M.L., Burton M.P., Allred D.C., Nicholls J.M., Amin M.B., Ro J.Y., and Schneider B.G. Epstein-Barr virus infection is associated with p53 accumulation in nasopharyngeal carcinoma. Hum. Pathol. 29 (1998) 252-259
7. s by in situ hybridization. Proc. Natl. Acad. Sci. USA 83 (1986) 9006-9010
8. Huang Q., Petros A.M., Virgin H.W., Fesik S.W., and Olejniczak E.T. Solution structure of the BHRF1 protein from Epstein-Barr virus, a homolog of human Bcl-2. J. Mol. Biol. 332 (2003) 1123-1130
9. Hussain S.P., and Harris C.C. Molecular epidemiology and carcinogenesis: endogenous and exogenous carcinogens. Mutat. Res. 462 (2000) 311-322
10. IARC, 1994. Infection with Helicobacter pylori. In: IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans. Schistosomes, Liver Flukes and Helicobacter pylori. International Agency for Research on Cancer. Lyon, 61, 177-240.
11. Ishii H.H., Gobe G.C., Yoneyama J., Mukaide M., and Ebihara Y. Role of p53, apoptosis, and cell proliferation in early stage Epstein-Barr virus positive and negative gastric carcinomas. J. Clin. Pathol. 57 (2004) 1306-1311
12. Karran L., Gao Y., Smith P.R., and Griffin B.E. Expression of a family of complementary-strand transcripts in Epstein-Barr virus-infected cells. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 8058-8062
13. Kume T., Oshima K., Shinohara T., Takeo H., Yamashita Y., Shirakusa T., and Kikuchi M. Low rate of apoptosis and overexpression of bcl-2 in Epstein-Barr virus-associated gastric carcinoma. Histopathology 34 (1999) 502-509
14. Labrecque L.G., Barnes D.M., Fentiman I.S., and Griffin B.E. Epstein-Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res. 55 (1995) 39-45
15. Mauser A., Saito S., Appella E., Anderson C.W., Seaman W.T., and Kenney S. The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms. J. Virol. 76 (2002) 12503-12512
16. Miller G. The switch between latency and replication of Epstein-Barr virus. J. Infect. Dis. 161 (1990) 833-844
17. Moritani S., Sugihara H., Kushima R., and Hattori T. Different roles of p53 between Epstein-Barr virus-positive and -negative gastric carcinomas of matched histology. Virchows Arch. 440 (2002) 367-375
18. Petit B., Leroy K., Kanavaros P., Boulland M.-L., Druet-Cabanac M., Haioun C., Bordessoule D., and Gaulard P. Expression of p53 protein in T- and natural killer cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations. Hum. Pathol. 32 (2001) 196-204
19. Poremba C., Yandell D.W., Huang Q., Little J.B., Mellin W., Schmid K.W., Bocker W., and Dockhorn-Dworniczak B. Frequency and spectrum of p53 mutations in gastric cancer-a molecular genetic and immunohistochemical study. Virchows Arch. 426 (1995) 447-455
20. Roux F.L., and Joab I. Epstein-Barr virus and nasopharyngeal carcinoma. Epstein-Barr Virus Rep. 5 (1998) 53-57
21. Sheng W., Decaussin G., Ligout A., Takada K., and Ooka T. Malignant transformation of Epstein-Barr virus-negative Akata cells by introduction of the BARF1 gene carried by Epstein-Barr virus. J. Virol. 77 (2003) 3859-3865
22. Shiao Y.H., Rugge M., Correa P., Lehmann H.P., and Scheer W.D. p53 alteration in gastric precancerous lesions. Am. J. Pathol. 144 (1994) 511-517
23. Shibata A., Parsonnet J., Longacre T.A., Garcia M.I., Puligandla B., Davis R.E., Vogelman J.H., Orentreich N., and Habel L.A. CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma. Carcinogenesis 23 (2002) 419-424
24. Sugiura M., Imai S., Tokunaga M., Koizumi S., Uchizawa M., Okamoto K., and Osato T. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma; unique viral latency in the tumour cells. Br. J. Cancer 74 (1996) 625-631
25. Szkaradkiewicz A., Kruk-Zagajewska A., Wal M., Jopek A., Wierzbicka M., and Kuch A. Epstein-Barr virus and human papillomavirus infections and oropharyngeal squamous cell carcinomas. Clin. Exp. Med. 2 (2002) 137-141
26. Szkaradkiewicz A., Wal M., Kuch A., and Pieta P. Human papillomavirus (HPV) and Epstein-Barr virus (EBV) cervical infections in women with normal and abnormal cytology. Pol. J. Microbiol. 2 (2004) 95-97
27. Takada K. Epstein-Barr virus and gastric carcinoma. Mol. Pathol. 53 (2000) 255-261
28. Van Rees B.P., Caspers E., Zur Hausen A., van den Brule A., Drillenburg P., Weterman M.A.J., and Offerhaus G.J.A. Different pattern of allelic loss in Epstein-Barr virus-positive gastric cancer with emphasis on the p53 tumor suppressor pathway. Am. J. Pathol. 161 (2002) 1207-1213
29. Wang Y., Luo B., Yan L.-P., Huang B.-H., and Zhao P. Relationship between Epstein-Barr virus-encoded proteins with cell proliferation, apoptosis, and apoptosis-related proteins in gastric carcinoma. World J. Gastroenterol. 11 (2005) 3234-3239
30. Watanabe H., Jass J.R., and Sobin L.H. Histological Typing of Oesophageal and Gastric Tumours. Second Edition. (1990), Springer-Verlag, Berlin, Heidelberg, New York pp. 19-26
31. Zhang Z., Yuan Y., Gao H., Dong M., Wang L., and Gong Y.H. Apoptosis, proliferation and p53 gene expression of H. pylori associated gastric epithelial lesions. World J. Gastroenterol. 7 (2001) 779-782
32. Zur Hausen A., Brink A.A., Craanen M.E., Middeldorp J.M., Meijer C.J., and van den Brule A.J. Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric carcinomas: expression of the transforming BARF1 gene. Cancer Res. 60 (2000) 2745-2748